The SIO NCCN Task Force submitted recommendations to the NCCN for the latest revision of the Neuroendocrine Tumor treatment guidelines. Rony Avritscher from MD Anderson Cancer Center, Nick Fidelman from UCSF, and Etay Ziv from Memorial Sloan Kettering Cancer Center authored the SIO submission.
The COVID-19 pandemic presents us with a crisis of significant magnitude with no clear end in sight. There are numerous stressors affecting our healthcare system, economy, and social lives. In the midst of all this, we face new challenges to our mission to advance the field of IO, particularly in re
COVID19 poses a real threat to the well-being of our patients and we, as physician-scientists, are taking this threat seriously. In light of the available data, we act diligently to protect those most vulnerable in this situation: our cancer patients. The necessary measures to mitigate the spread of
Posted By: Constantinos T Sofocleous, MD, PhD, FSIR, FCIRSE
Fri Apr 24th, 2020
Cancer care during the pandemic requires assessment of several factors that are specific to each patient as well as the curve of the pandemic in a particular location and the infrastructure capabilities at the center offering care. As a general approach, we consider continuation of cancer care unles
The COVID-19 pandemic has greatly impacted the entire patient experience in interventional oncology at our institution. This goes beyond the known infected patients or those under investigation with the newly expected, necessary personal protective equipment (PPE) and safety precautions taken. It a